journal article·2013-10-22

Functionalization-Dependent Induction of Cellular Survival Pathways by CdSe Quantum Dots in Primary Normal Human Bronchial Epithelial Cells

Amber Nagy, Jennifer A. Hollingsworth, Bin Hu, Andrea Steinbrück, Peter C. Stark, Cristina Rios Valdez, Momchilo Vuyisich, Michael H. Stewart, Donald H. Atha, Bryant C. Nelson, Rashi Iyer

ACS Nano· Volume 7· Issue 10
Publisher page

Abstract

Quantum dots (QDs) are semiconductor nanocrystals exhibiting unique optical properties that can be exploited for many practical applications ranging from photovoltaics to biomedical imaging and drug delivery. A significant number of studies have alluded to the cytotoxic potential of these materials, implicating Cd-leaching as the causal factor. Here, we investigated the role of heavy metals in biological responses and the potential of CdSe-induced genotoxicity. Our results indicate that, while negatively charged QDs are relatively noncytotoxic compared to positively charged QDs, the same does not hold true for their genotoxic potential. Keeping QD core composition and size constant, 3 nm CdSe QD cores were functionalized with mercaptopropionic acid (MPA) or cysteamine (CYST), resulting in negatively or positively charged surfaces, respectively. CYST-QDs were found to induce significant cytotoxicity accompanied by DNA strand breakage. However, MPA-QDs, even in the absence of cytotoxicity and reactive oxygen species formation, also induced a high number of DNA strand breaks. QD-induced DNA damage was confirmed by identifying the presence of p53 binding protein 1 (53BP1) in the nuclei of exposed cells and subsequent diminishment of p53 from cytoplasmic cellular extracts. Further, high-throughput real-time PCR analyses revealed upregulation of DNA damage and response genes and several proinflammatory cytokine genes. Most importantly, transcriptome sequencing revealed upregulation of the metallothionein family of genes in cells exposed to MPA-QDs but not CYST-QDs. These data indicate that cytotoxic assays must be supplemented with genotoxic analyses to better understand cellular responses and the full impact of nanoparticle exposure when making recommendations with regard to risk assessment.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticles: synthesis and applications · Carbon and Quantum Dots Applications · Nanocluster Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biochemistry & Molecular Biology, Georgetown University Medical Center, Washington, DC 20007, United States

Optical Sciences Division, Code 5611, U.S. Naval Research Laboratory, Washington, DC 20375, United States

Biochemical Science Division, National Institute of Standards and Technology, Gaithersburg, Maryland 20899, United States

Defense Systems and Analysis Division, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, United States

References (66)

Show source-provided references
1. Pal B. N. · Nano Lett. · 2012 · 12 · 33110.1021/nl203620f ↗
2. Milliron D. J. · Nature · 2004 · 430 · 19010.1038/nature02695 ↗
3. Mocatta D. · Science · 2011 · 332 · 7710.1126/science.1196321 ↗
4. Hu M. · ACS Nano · 2010 · 4 · 48810.1021/nn901404h ↗
5. Diagaradjane P. · Clin. Cancer Res. · 2008 · 14 · 73110.1158/1078-0432.CCR-07-1958 ↗
6. Walker K.-A. D. · PLoS ONE · 2012 · 7 · e3159210.1371/journal.pone.0031592 ↗
7. Bagalkot V. · Nano Lett. · 2007 · 7 · 306510.1021/nl071546n ↗
8. Muthu M. S. · Biomaterials · 2012 · 33 · 349410.1016/j.biomaterials.2012.01.036 ↗
9. Lovrić J. · J. Mol. Med. · 2005 · 83 · 37710.1007/s00109-004-0629-x ↗
10. Nagy A. · Chem. Res. Toxicol. · 2011 · 24 · 217610.1021/tx2003195 ↗
11. Nagy A. · ACS Nano · 2012 · 6 · 474810.1021/nn204886b ↗
12. Al-Hajaj N. A. · ACS Nano · 2011 · 5 · 490910.1021/nn201009w ↗
13. Hoshino A. · Nano Lett. · 2004 · 4 · 216310.1021/nl048715d ↗
14. Hoshino A. · Arch. Toxicol. · 2011 · 85 · 70710.1007/s00204-011-0695-0 ↗
15. Kelf T. A. · Nanotechnology · 2010 · 21 · 28510510.1088/0957-4484/21/28/285105 ↗
16. Nogueira C. · Arch. Toxicol. · 2011 · 85 · 131310.1007/s00204-011-0720-3 ↗
17. Nordberg G. F. · Toxicol. Appl. Pharmacol. · 2009 · 238 · 19210.1016/j.taap.2009.03.015 ↗
18. Waalkes M. P. · Mutat. Res., Fundam. Mol. Mech. Mutagen. · 2003 · 533 · 10710.1016/j.mrfmmm.2003.07.011 ↗
19. Li K. G. · Toxicol. in Vitro · 2009 · 23 · 100710.1016/j.tiv.2009.06.020 ↗
20. Derfus A. M. · Nano Lett. · 2004 · 4 · 1110.1021/nl0347334 ↗
21. Kirchner C. · Nano Lett. · 2005 · 5 · 33110.1021/nl047996m ↗
22. Lee H. M. · Toxicol. Appl. Pharmacol. · 2009 · 238 · 16010.1016/j.taap.2009.05.010 ↗
23. Lovrić J. · Chem. Biol. · 2005 · 12 · 122710.1016/j.chembiol.2005.09.008 ↗
24. Foldbjerg R. · Arch. Toxicol. · 2011 · 85 · 74310.1007/s00204-010-0545-5 ↗
25. Kim H. R. · Mutat. Res., Fundam. Mol. Mech. Mutagen. · 2011 · 726 · 129
26. Shukla R. K. · Toxicol. in Vitro · 2011 · 25 · 23110.1016/j.tiv.2010.11.008 ↗
27. Shukla R. K. · Nanotoxicology · 2011 · 7 · 4810.3109/17435390.2011.629747 ↗
28. Jugan M.-L. · Nanotoxicology · 2011 · 6 · 50110.3109/17435390.2011.587903 ↗
29. Khalil W. K. · Chem. Res. Toxicol. · 2011 · 24 · 64010.1021/tx2000015 ↗
30. Jacobsen N. R. · Part. Fibre Toxicol. · 2009 · 6 · 210.1186/1743-8977-6-2 ↗
31. Wang L. · J. Nanosci. Nanotechnol. · 2010 · 10 · 859110.1166/jnn.2010.2681 ↗
32. Pala I. R. · Angew. Chem. · 2010 · 122 · 374310.1002/ange.201000034 ↗
33. Aldana J. · J. Am. Chem. Soc. · 2001 · 123 · 884410.1021/ja016424q ↗
34. Dollefeld H. · Phys. Chem. Chem. Phys. · 2002 · 4 · 474710.1039/B202101C ↗
35. Susumu K. · Nat. Protoc. · 2009 · 4 · 42410.1038/nprot.2008.247 ↗
36. Susumu K. · J. Am. Chem. Soc. · 2007 · 129 · 1398710.1021/ja0749744 ↗
37. Lankoff A. · Toxicol. Lett. · 2012 · 208 · 19710.1016/j.toxlet.2011.11.006 ↗
38. Yan M. · Toxicology · 2011 · 282 · 9410.1016/j.tox.2011.01.015 ↗
39. Faux S. P. · Biomarkers · 2009 · 14 · 9010.1080/13547500902965047 ↗
40. Shih R. S. · Exp. Biol. Med. · 2008 · 233 · 31710.3181/0708-RM-220 ↗
41. Ricks-Santi L. J. · BMC Cancer · 2011 · 11 · 27810.1186/1471-2407-11-278 ↗
42. Beger C. · Clin. Cancer Res. · 2004 · 10 · 378010.1158/1078-0432.CCR-0992-3 ↗
43. Chabalier C. · Cell Cycle · 2006 · 5 · 100110.4161/cc.5.9.2726 ↗
44. Deng C. X. · Nucleic Acids Res. · 2006 · 34 · 141610.1093/nar/gkl010 ↗
45. Badie C. · Mol. Cell. Biol. · 2000 · 20 · 235810.1128/MCB.20.7.2358-2366.2000 ↗
46. Noon A. T. · DNA Repair · 2011 · 10 · 107110.1016/j.dnarep.2011.07.012 ↗
47. Sutter T. R. · J. Biol. Chem. · 1994 · 269 · 1309210.1016/S0021-9258(17)36803-5 ↗
48. Omura T. · J. Biol. Chem. · 1964 · 239 · 237010.1016/S0021-9258(20)82244-3 ↗
49. Hayes C. L. · Proc. Natl. Acad. Sci. U.S.A. · 1996 · 93 · 977610.1073/pnas.93.18.9776 ↗
50. McKenna I. M. · Toxicol. Appl. Pharmacol. · 1998 · 153 · 16910.1006/taap.1998.8399 ↗
51. Wicherek L. · Reprod. Biol. Endocrinol. · 2006 · 4 · 4110.1186/1477-7827-4-41 ↗
52. King-Heiden T. C. · Environ. Sci. Technol. · 2009 · 43 · 160510.1021/es801925c ↗
53. George S. · ACS Nano · 2011 · 5 · 180510.1021/nn102734s ↗
54. Oberdorster G. · Environ. Health Perspect. · 1994 · 102 · 257
55. Ho C.-C. · Nanotoxicology · 2011 · 7 · 105
56. Ma-Hock L. · Toxicol. Lett. · 2012 · 208 · 11510.1016/j.toxlet.2011.10.011 ↗
57. Chau E. · Nanotoxicology · 2012 · 7 · 114310.3109/17435390.2012.711862 ↗
58. Mahler B. · J. Am. Chem. Soc. · 2009 · 132 · 95310.1021/ja9034973 ↗
59. Yu W. W. · Chem. Mater. · 2003 · 15 · 285410.1021/cm034081k ↗
60. Petersen E. J. · Anal. Bioanal. Chem. · 2010 · 398 · 61310.1007/s00216-010-3881-7 ↗
61. Gao J. · Toxicol. Appl. Pharmacol. · 2010 · 244 · 13010.1016/j.taap.2009.12.025 ↗
62. Langmead B. · Genome Biol. · 2009 · 10
63. Roberts A. · Genome Biol. · 2011 · 12 · R2210.1186/gb-2011-12-3-r22 ↗
64. Roberts A. · Bioinformatics · 2011 · 27 · 232510.1093/bioinformatics/btr355 ↗
65. Trapnell C. · Nat. Protoc. · 2012 · 7 · 56210.1038/nprot.2012.016 ↗
66. Trapnell C. · Nat. Biotechnol. · 2010 · 28 · 51610.1038/nbt.1621 ↗